Call for Abstract
21st Euro Biotechnology Congress, will be organized around the theme “Innovations and challenges in Biotechnology”
Euro Biotechnology 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Biotechnology 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Pharmaceutical Biotechnology is the science that covers all technologies required for producing, manufacturing and registration of biological drugs. Pharmaceutical companies use biotechnology for manufacturing drugs, pharmacogenomics, gene therapy, and genetic testing. Biotech companies make biotechnology products by manipulating and modifying organisms, usually at molecular level. Pharmaceutical Biotechnology is an increasingly important area of science and technology. It contributes in design and delivery of new therapeutic drugs, diagnostic agents for medical tests, and in gene therapy for correcting the medical symptoms of hereditary diseases. The Pharmaceutical Biotechnology is widely spread, ranging from many ethical issues to changes in healthcare practices and a significant contribution to the development of national economy. Euro Biotechnology 2018 will focus on Biopharmaceuticals Discovery, Biopharmaceutical Regulations and Validations, Biologics and Biosimilars and Clinical Research/Clinical trials.
- Track 1-1Biopharmaceuticals Discovery
- Track 1-2Biopharmaceutical Regulations and Validations
- Track 1-3Biologics and Biosimilars
- Track 1-4Clinical Research/Clinical trials
Medicine is by means of biotechnology techniques so much in diagnosing and treating dissimilar diseases. It also gives opportunity for the population to defend themselves from hazardous diseases. The pasture of biotechnology, genetic engineering, has introduced techniques like gene therapy, recombinant DNA technology and polymerase chain retort which employ genes and DNA molecules to make a diagnosis diseases and put in new and strong genes in the body which put back the injured cells. There are some applications of biotechnology which are live their part in the turf of medicine and giving good results.
- Track 2-1Biopharmaceutical Manufacturing
- Track 2-2Biomedical Signal Processing
- Track 2-3Biomechanics & Biomedical Modeling
- Track 2-4Clinical Research/Clinical trials
- Track 2-5Biomarkers
- Track 2-6Microarray Technology
- Track 2-7Pharmacogenomics (personalized medicine)
- Track 2-8Biomedical Imaging
- Track 2-9Diagnostics
- Track 2-10Biomaterials and Biopharmacy
A biomaterial is any substance that has been engineered to interact with biological systems for a medical purpose - either a therapeutic (treat, augment, repair or replace a tissue function of the body) or a diagnostic one. It has experienced steady and strong growth over its history, with many companies investing large amounts of money into the development of new products. Biomaterials science encompasses elements of medicine, biology, chemistry, tissue engineering and materials science. They are often used and/or adapted for a medical application, and thus comprises whole or part of a living structure or biomedical device which performs, augments, or replaces a natural function. Such functions may be relatively passive, like being used for a heart valve, or may be bioactive with a more interactive functionality such as hydroxy-apatite coated hip implants. Biomaterials are also used every day in dental applications, surgery, and drug delivery.
Industrial biotechnology is the application of biotechnology for industrial purposes, including industrial fermentation. The practice of using cells such as micro-organisms, or components of cells like enzymes, to generate industrially useful products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles and biofuels. Industrial Biotechnology offers a premier forum bridging basic research and R&D with later-stage commercialization for sustainable bio based industrial and environmental applications.
- Track 4-1Bio-Fuels
- Track 4-2Energy Crops (cellulosic ethanol industry)
- Track 4-3Industrial Enzymes
- Track 4-4Bioprocess Engineering and Optimization
- Track 4-5Policies and Incentives for Industrial Biotech
- Track 4-6Biorefineries: Building the Bioeconomy
Biotechnology has the ability to solve the upcoming problems of the world’s increasing population. However, there is often reluctance among the public to accept and support biotechnological products in medicine, industry, or agriculture. There are many safety and ethical issues raised for GM crops and human cloning. Raising transgenic animals and plants has fueled ethical concerns, and the scientists have faced a lot of resistance where genetically modified crop plants or reproductive cloning research of human beings is involved. Thus, biosafety and bioethics are continuously being expanded to combine the rationale of ever-increasing scientific knowledge in biotechnology that is often in conflict with the long-standing social and moral value system of our society.
- Track 5-1Biosafety Regulations
- Track 5-2Intellectual Property Rights
- Track 5-3Ethical Issues of Human Genome Project
- Track 5-4Ethical Issues of Organs Transplantation
- Track 5-5Ethical Issues of Stem Cell Research
- Track 5-6Handling and Disposal of Hazardous Materials
A bioprocess is a specific process that uses complete living cells or their components to obtain desired products. Transport of energy and mass is fundamental to many biological and environmental processes. Areas, from food processing to thermal design of building to biomedical devices to pollution control and global warming, require knowledge of how energy and mass can be transported through materials.
- Track 6-1Biomolecular Engineering
- Track 6-2Fermentation Aspects in New Product Development
- Track 6-3Fermentation Extravaganza: A new revolution for Food and Beverages
- Track 6-4Application of Enzymes in Bioprocess
- Track 6-5Bioreactors and cell culture systems
- Track 6-6Biosensor and Bioelectronics
- Track 6-7Bioseparation and Biopurification
- Track 6-8Biosynthesis and Metabolic Engineering
- Track 6-9Biocatalysis & Biotransformation
- Track 6-10Upstream and Downstream Bioprocessing
Nanobiotechnology, bio nanotechnology, and Nano biology are terms that refer to the intersection of nanotechnology and biology. Bio nanotechnology and Nano biotechnology serve as blanket terms for various related technologies. The most important objectives that are frequently found in Nano biology involve applying Nano tools to relevant medical/biological problems and refining these applications. Developing new tools, such as peptide Nano sheets, for medical and biological purposes is another primary objective in nanotechnology.
- Track 7-1Disease Diagnosis
- Track 7-2Drug Delivery
- Track 7-3Biosensors
- Track 7-4Nanofabricated Devices
- Track 7-5DNA Nanobiotechnology
- Track 7-6Lipid Nanotechnology
- Track 7-7Future prospects of Nanobiotechnology
Biotechnology has application in four major industrial areas, including health care (medical), crop production and agriculture, nonfood (industrial) uses of crops and other products (e.g. biodegradable plastics, vegetable oil, biofuels), and environmental uses. Applied Microbiology and Biotechnology focusses on prokaryotic or eukaryotic cells, relevant enzymes and proteins, applied genetics and molecular biotechnology, genomics and proteomics, applied microbial and cell physiology, environmental biotechnology, process and products and more.
- Track 8-1Biotechnology and Bioprocessing
- Track 8-2Tissue culture
- Track 8-3Protein Engineering
- Track 8-4Cloning, Recombinant Selection and Expression
- Track 8-5Reproduction
- Track 8-6Molecular Farming
- Track 8-7Trangenics and Gene Therapy
- Track 8-8Tools and Techniques of Molecular Biology
- Track 8-9Forensic Sciences
Biotechnology is a field where technology advances rapidly but returns on investments may be slow. For this reason, it is important for public research organisations and enterprises to protect the innovation that they generate with Intellectual Property Rights (IPR), which provide a basis for return on investment in research and development, by granting monopoly rights for a certain period of time to their owners. The IP created by biotechnology companies that can take a number of different forms, consisting of vaccines, seeds, plants, medical devices and software, but also brands and domain names, among others. Most of these different assets may attract more than one form of IP protection. In the biotechnology sector the most relevant form of IP are patents, although other forms are also applicable and used in practice.
- Track 9-1Patents
- Track 9-2Plant Breeder’s Rights and Farmer’s Variety Act
- Track 9-3Copyrights
- Track 9-4Trade Secrets
Biotechnology products arise from successful biotech companies. Entrepreneurs start biotechnology companies for various reasons, but creating revolutionary products and tools that impact the lives of potentially millions of people is one of the fundamental reasons why all entrepreneurs start biotechnology companies. Certainly, biotech entrepreneurs hope to make truckloads of money by building successful companies with billions in revenue. But most biotech entrepreneurs have an altruistic streak fueling their persistence, which keeps them going through the hardships and challenges that would stop cold those just looking to make a quick buck. The main focus is laid on Strategic Alliances, Partnering Trends, Product Opportunities, Business Models and Strategies, Merger and Acquisitions, Licensing and Growth.
- Track 10-1Strategic Alliances
- Track 10-2Partnering Trends
- Track 10-3Product Opportunities
- Track 10-4Business Models and Strategies
- Track 10-5Merger and Acquisitions
- Track 10-6Licensing and Growth
Genome editing and the utilization of CRISPR based technologies are expected to revolutionize the production of the next generation of bioproducts. Euro Biotechnology 2018 will focus on the latest developments in the use of CRISPR/Cas9 and other CRISPR based technologies in relation to the development and production of biopharmaceuticals, biochemicals, agricultural crops and translational applications
- Track 11-1Drug Screening
- Track 11-2Production of bio-pharmaceuticals
- Track 11-3Plant Cell Factories and Agro-Science
- Track 11-4Mammalian and Microbial Cell Factories
- Track 11-5Tools and Future Directions
The biotechnology is applied and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. It is "the development, use and regulation of biological systems for remediation of contaminated environment and for environment-friendly processes (green manufacturing technologies and sustainable development). Environmental biotechnology can simply be described as "the optimal use of nature, in the form of plants, animals, bacteria, fungi and algae, to produce renewable energy, food and nutrients in a synergistic integrated cycle of profit making processes where the waste of each process becomes the feedstock for another process".
- Track 12-1Biotreatment of Solid, Liquid, and Gaseous Wastes
- Track 12-2Bioremediation of Polluted Environments
- Track 12-3Biomonitoring
- Track 12-4Innovative Biological Approaches to Pollution Prevention and Waste Management
- Track 12-5Phytoremediation, Biological Treatment of Domestic and Industrial Wastewaters
Plant Biotechnology is prominent in the field of medicine interfacing biotechnology and bioinformatics, the molecular characterization of medicinal plants; molecular farming; and result from chemistry, nanotechnology, pharmacology, agriculture, Biomass and biofuels as well. Plant Biotechnology is the technology which is used for getting modern product with high yield and at faster rate. Biotechnology is being used as a tool to grow trees with special characteristics. When used responsibly, society and the environment can benefit from advanced tree breeding technologies. The next few years will be a time of rapid expansion for biotech trees throughout the world in an attempt to meet global demand for forest products and to protect future forests against increasing demand.
- Track 13-1Applications of Plant Biotechnology
- Track 13-2Plant Tissue Culture Techniques
- Track 13-3Molecular Farming and Applications
- Track 13-4GM Crops
- Track 13-5Transgenic Plants and Crops
Modern biotechnology can play an important role in meeting our future food demands in a sustainable manner. Biotech can increase crop yields, help develop new crops, and adapt existing crops to be cultivated on marginal lands with reduced fresh-water inputs. The technology may not only improve the nutritional quality of staple foods, but can also diminish the need to cultivate crops on deforested land. Rapid advances in biotechnology are reducing the time and cost to develop improved food and feed strains and to engineer crops with improved drought and salinity tolerance and improved nutritional quality. New biotechnology tools enable scientists to introduce biochemical pathways to cells so we can breed plants that are safe and cost-effective sources of these nutrients.
- Track 14-1Food Microbiology
- Track 14-2Recombinant DNA Techniques
- Track 14-3Indigenous Food Production
- Track 14-4Fermentation Processes
- Track 14-5GM Foods
- Track 14-6Human Nutrition and Metabolism
- Track 14-7Food Safety
- Track 14-8Current Status and Future Prospects of Food Biotechnology
Marine biotechnology, sometimes referred to as “blue biotechnology”, exploits the diversity found in marine environments in terms of the form, structure, physiology and chemistry of marine organisms, many of which have no equivalent on land, in ways which enable new materials to be realised. Marine biotechnology is a knowledge generation and conversion process: it unlocks access to biological compounds and provides novel uses for them. By exploring and harnessing marine materials, entirely new uses in areas far from the marine are likely to be found. Marine biotechnology is an opportunity recognised by policy makers and the enterprise sector as offering significant potential to fill market gaps for new products.
- Track 15-1Environment Applications of Marine Biotechnology
- Track 15-2Marine Natural Products
- Track 15-3Bio products and Bioactive Compounds
- Track 15-4Marine Microbiology and Biodiversity
- Track 15-5Marine-based Drug Discovery & Development
- Track 15-6Genomics and Proteomics of Marine Organisms
- Track 15-7Aquatic Microbial Ecology
Biodegradation is the biological process in which a material is biologically degraded. It is a natural process that takes place without human intervention. Bioremediation is the engineered process of application of biological means (including bacteria, algae, fungi, etc.) to degrade a material. Biodegradation is a slow process process, while bioremediation is a faster process. Human intervention is used to control the rate of bioremediation, by control of temperature, availability of food or nutrients, etc. Biodegradation, on the other hand, is controlled by nature. Biodegradation takes place anywhere and everywhere, while bioremediation is planned at a contaminated site. Biodegradation can be both beneficial and harmful (such as degradation of metals in biofouling), while bioremediation is designed to be beneficial to us.
- Track 16-1 Emerging Technologies to Analyze Natural Attenuation and Bioremediation
- Track 16-2 Biocatalytic Applications of the Pollutant Degradation Machinery
- Track 16-3Bioavailability, Chemotaxis and Transport of Organic Pollutants
- Track 16-4Signalling Networks and Pollutant Biosensors
Protein engineering has emerged as an important tool to overcome the limitations of natural enzymes as biocatalysts. Recent advances have mainly focused on applying directed evolution to enzymes, especially important for organic synthesis, such as monooxygenases, ketoreductases, lipases or aldolases in order to improve their activity, enantioselectivity, and stability. The combination of directed evolution and rational protein design using computational tools is becoming increasingly important in order to explore enzyme sequence-space and to create improved or novel enzymes.
Bioenergy is the chemical energy contained in organic matter (biomass) which can be converted into energy forms that we can use directly, such as electricity, heat and liquid fuel.Biomass is any organic matter of recently living plant or animal origin. Unlike coal, the organic matter is not fossilised.Traditionally mainly woody biomass has been used for bioenergy, however more recent technologies have expanded the potential resources to those such as agricultural residues, oilseeds and algae. These advanced bioenergy technologies allow for the sustainable development of the bioenergy industry, without competing with the traditional agricultural industry for land and resources. Bioenergy plants can range from small domestic heating systems to multi-megawatt industrial plants requiring hundreds of thousands of tonnes of biomass fuel each year. A variety of technologies exists to release and use the energy contained in biomass.They range from combustion technologies that are well proven and widely used around the world for generating electricity generation, to emerging technologies that convert biomass into liquid fuels for road, sea and air transport.
- Track 19-1Bioenergy Processes
- Track 19-2Bioenergy Utilization
- Track 19-3Biomass and The Environment
- Track 19-4Sustainability and Biodiversity Issues
- Track 19-5Economic Aspects of Biomass and Bioenergy
- Track 19-6Biomass and Feedstock Utilization
Animal biotechnology is a branch of biotechnology in which molecular biology techniques are used to genetically engineer (i.e. modify the genome of) animals in order to improve their suitability for pharmaceutical, agricultural or industrial applications. It covers the identification and manipulation of genes and their products, stressing applications in domesticated animals. Animal biotechnology has been used to produce genetically modified animals that synthesize therapeutic proteins, have improved growth rates or are resistant to disease.